PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
3.77%
Revenue growth above 1.5x 2127.T's 1.99%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
2.33%
Gross profit growth under 50% of 2127.T's 7.16%. Michael Burry would be concerned about a severe competitive disadvantage.
7.47%
EBIT growth 50-75% of 2127.T's 11.22%. Martin Whitman would suspect suboptimal resource allocation.
11.60%
Operating income growth above 1.5x 2127.T's 7.11%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
7.06%
Net income growth at 50-75% of 2127.T's 12.07%. Martin Whitman would question fundamental disadvantages in expenses or demand.
7.10%
EPS growth at 50-75% of 2127.T's 12.59%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
7.10%
Diluted EPS growth at 50-75% of 2127.T's 12.59%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
0.00%
Share reduction more than 1.5x 2127.T's 0.19%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
0.00%
Diluted share reduction more than 1.5x 2127.T's 0.19%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
-113.60%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-470.38%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
30.78%
10Y revenue/share CAGR under 50% of 2127.T's 133.24%. Michael Burry would suspect a lasting competitive disadvantage.
30.78%
5Y revenue/share CAGR under 50% of 2127.T's 133.24%. Michael Burry would suspect a significant competitive gap or product weakness.
30.78%
3Y revenue/share CAGR under 50% of 2127.T's 133.24%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
73.51%
10Y OCF/share CAGR under 50% of 2127.T's 1092.33%. Michael Burry would worry about a persistent underperformance in cash creation.
73.51%
Below 50% of 2127.T's 1092.33%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
73.51%
3Y OCF/share CAGR under 50% of 2127.T's 1092.33%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
96.43%
Below 50% of 2127.T's 542.43%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
96.43%
Below 50% of 2127.T's 542.43%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
96.43%
Below 50% of 2127.T's 542.43%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
48.59%
10Y equity/share CAGR above 1.5x 2127.T's 29.91%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
48.59%
5Y equity/share CAGR above 1.5x 2127.T's 29.91%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
48.59%
3Y equity/share CAGR above 1.5x 2127.T's 29.91%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.84%
Inventory is declining while 2127.T stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-1.83%
Negative asset growth while 2127.T invests at 6.43%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
4.96%
Similar to 2127.T's 5.18%. Walter Schloss finds parallel capital usage or profit distribution strategies.
-10.36%
We’re deleveraging while 2127.T stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.